ABMED · GLOBAL REGULATORY & MARKET ACCESS

North and Central American markets

38 international markets (countries and regional markets) in our service materials; each jurisdiction has its own requirements.

Find your target market

Health Canada

Canada

Market access overview

Class I generally does not require an MDL, while establishment MDEL obligations must still be assessed. Classes II–IV require the applicable MDL and MDSAP quality evidence.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

COFEPRIS

Mexico

Market access overview

Assess COFEPRIS classification and the currently available ordinary or reliance route for the specific product. Foreign approvals or free-sale certificates do not automatically establish Mexican acceptance.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

FDA

United States

Market access overview

FDA device classification and product code determine whether exemption, 510(k), De Novo or PMA applies. Establishment registration and listing do not constitute FDA approval.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Ministry of Health

Costa Rica

Market access overview

Assess the EMB category and risk class under Costa Rica’s applicable framework, local applicant responsibility, Spanish evidence and the registration/import arrangements.

Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.

Regulator reference ↗

Discuss this market

Based on the regulatory section of ABMED’s 38-market report, with source material dated 17 November 2026. Confirm current rules and the specific product before implementation. Market coverage does not imply a company office in every market.